tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Hazlett, 55 are a BUY (88.71%), 6 are a HOLD (9.68%), 1 are a SELL (1.61%).
Analyst Robert Hazlett, carries an average stock price target met ratio of 23.68% that have a potential upside of 26.24% achieved within 128 days. Previously, Robert Hazlett worked at BTIG.
Robert Hazlett’s has documented 110 price targets and ratings displayed on 18 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AURA, Aura Biosciences at 08-Dec-2023.
Analyst best performing recommendations are on AXSM (AXSOME THERAPEUTICS).
The best stock recommendation documented was for AXSM (AXSOME THERAPEUTICS) at 12/17/2019. The price target of $97 was fulfilled within 3 days with a profit of $16.03 (19.8%) receiving and performance score of 65.99.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$100
$-26.2 (-20.76%)
$100
8 days ago
(13-Jan-2025)
24/25 (96%)
$-27.71 (-21.70%)
165
Buy
$89
$-37.2 (-29.48%)
$81
2 months 17 days ago
(04-Nov-2024)
9/9 (100%)
$2.02 (2.32%)
43
Buy
$95
$-31.2 (-24.72%)
$80
3 months 10 days ago
(11-Oct-2024)
4/4 (100%)
$19.24 (25.40%)
323
Buy
$108
$-18.2 (-14.42%)
$106
3 months 17 days ago
(04-Oct-2024)
21/21 (100%)
$35.11 (48.17%)
244
Buy
$130
$3.8 (3.01%)
$130
4 months 1 days ago
(20-Sep-2024)
26/29 (89.66%)
$52.39 (67.50%)
497
What Year was the first public recommendation made by Robert Hazlett?
